Subcutaneous injection

Results: 71



#Item
31How to Administer IM (Intramuscular) Injections and SQ (Subcutaneous) Injections - Minnesota Dept. of Health

How to Administer IM (Intramuscular) Injections and SQ (Subcutaneous) Injections - Minnesota Dept. of Health

Add to Reading List

Source URL: www.health.state.mn.us

Language: English - Date: 2012-07-05 10:10:36
32How to Administer IM and SC Injections to Adults

How to Administer IM and SC Injections to Adults

Add to Reading List

Source URL: www.immunizepa.org

Language: English - Date: 2013-04-10 15:43:02
33Michigan Department of Community Health Division of Chronic Disease and Injury Control Diabetes and Other Chronic Diseases Section Washington Square Bldg. 7th Floor 109 W. Michigan Ave Lansing MI 48913

Michigan Department of Community Health Division of Chronic Disease and Injury Control Diabetes and Other Chronic Diseases Section Washington Square Bldg. 7th Floor 109 W. Michigan Ave Lansing MI 48913

Add to Reading List

Source URL: www.michigan.gov

Language: English - Date: 2014-07-23 11:22:50
34Position Statement on Injection Technique March[removed]Royal College of Paediatrics

Position Statement on Injection Technique March[removed]Royal College of Paediatrics

Add to Reading List

Source URL: www.rcn.org.uk

Language: English - Date: 2007-10-02 05:04:07
35Error-prone abbreviations, symbols and dose designations not to use Error-prone abbreviations, symbols and dose designations not to use

Error-prone abbreviations, symbols and dose designations not to use Error-prone abbreviations, symbols and dose designations not to use

Add to Reading List

Source URL: www.hqsc.govt.nz

Language: English - Date: 2014-07-10 18:39:23
36TITLE  PHARMACIST ADMINISTRATION OF INTRAMUSCULAR OR SUBCUTANEOUS MEDICATIONS DOCUMENT #  INITIAL APPROVAL DATE

TITLE PHARMACIST ADMINISTRATION OF INTRAMUSCULAR OR SUBCUTANEOUS MEDICATIONS DOCUMENT # INITIAL APPROVAL DATE

Add to Reading List

Source URL: extranet.ahsnet.ca

Language: English - Date: 2014-06-27 15:03:43
37Dear Healthcare Professional Letter of Rapid Safety Communication September 2012 RANMARK SUBCUTANEOUS INJECTION 120mg (denosumab) -Risk of severe hypocalcaemia, including fatal cases 11 September 2012 Dear Healthcare P

Dear Healthcare Professional Letter of Rapid Safety Communication September 2012 RANMARK SUBCUTANEOUS INJECTION 120mg (denosumab) -Risk of severe hypocalcaemia, including fatal cases 11 September 2012 Dear Healthcare P

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2012-09-12 05:48:19
38PRIOR AUTHORIZATION POLICY Stelara™ (ustekinumab for subcutaneous [SC] injection – Centocor Ortho Biotech) To Initiate a Coverage Review, Call[removed]For Coverage Under the Medical Benefit, Call[removed]

PRIOR AUTHORIZATION POLICY Stelara™ (ustekinumab for subcutaneous [SC] injection – Centocor Ortho Biotech) To Initiate a Coverage Review, Call[removed]For Coverage Under the Medical Benefit, Call[removed]

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-08-12 13:02:44
39PRIOR AUTHORIZATION POLICY Ilaris® (canakinumab for subcutaneous [SC] injection Novartis)  To initiate a Coverage Review, Call[removed]

PRIOR AUTHORIZATION POLICY Ilaris® (canakinumab for subcutaneous [SC] injection Novartis) To initiate a Coverage Review, Call[removed]

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2013-11-01 14:13:13
40Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the

Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the

Add to Reading List

Source URL: www.vivitrolrems.com

Language: English - Date: 2013-08-01 17:58:38